IDSA members at Cleveland Clinic, Steven Schmitt, MD, FIDSA; Adarsh Bihmraj, MD, FIDSA; and Steve Gordon, MD, FIDSA, Chief of the Infectious Diseases Department, recently hosted congressional staffer for U.S. Senator Rob Portman (R-OH) Josh Prest for a tour of the clinic’s ID department, and a discussion about the value of infectious diseases physicians to patient care and innovation in therapeutics, diagnostics, and vaccines.
IDSA Presents Priorities at World Health Assembly 2018-05-29 The Infectious Diseases Society of America participated in the 71st World Health Assembly in Geneva during the week of May 21 -25, presenting and joining statements reflecting IDSA priorities.
HCVguidelines.org — a website developed by the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) to provide up-to-date guidance on the management of hepatitis C (HCV) — has updated several sections of the website to reflect new testing and management recommendations for pregnant women, people who inject drugs, men who have sex with men and people who are incarcerated.
More than 900 physicians, scientists and researchers confronting tuberculosis across communities in the United States and around the world have signed a letter urging U.S. Ambassador to the United Nations Nikki Haley to ensure that the September UN General Assembly High Level Meeting Ending Tuberculosis leads to concrete commitments aimed at eliminating the impacts of the world’s leading infectious disease killer.
The Ebola outbreak in the Democratic Republic of Congo announced May 8 has highlighted meaningful advances as well as critical needs that continue in the wake of the epidemic across Sierra Leone, Guinea and Liberia that ended two years ago.
The Infectious Diseases Society of America, the HIV Medicine Association the Pediatric Infectious Diseases Society and the Society for Healthcare Epidemiology of America call on Congress to reject legislative attempts, including House Resolution 3 introduced Wednesday evening, that advance the Trump administration’s rescissions package.
The Eliminating Opioid-Related Infectious Disease Act and the Substance Use Disorder Loan Repayment Act under consideration by the House Energy and Commerce Committee today recognize that responses to the national opioid epidemic must include responses to its accompanying public and individual health threats.
The Vital Signs report data released today by the Centers for Disease Control and Prevention (CDC) show significant increases in vector-borne diseases in the United States highlighting the need for improved strategies to protect patients and public health.
The Infectious Diseases Society of America, the HIV Medicine Association, and the Pediatric Infectious Diseases Society commend House and Senate panels approving legislation this week that demonstrated a commitment to confronting the opioid crisis comprehensively and effectively.
World Immunization Week from April 24-30 gives us the opportunity to celebrate one of the greatest achievements of modern medicine. Safe and effective vaccines that protect individuals against diphtheria, hepatitis B, measles, mumps, pertussis, rubella, human papilloma virus,and polio have drastically limited the incidence of these serious, sometimes life-threatening diseases in many parts of the world.
The Infectious Diseases Society of America appreciates the attention that the World Bank and International Monetary Fund will give to critical global health issues during their spring meetings and civil society forum.
The U.S. government response to the global impacts of HIV and tuberculosis is poised at a pivotal moment, in which we can seize the opportunity to end these devastating pandemics, or watch progress erode, infections increase, and our effective treatments compromised by growing drug resistance.